f**********g 发帖数: 2252 | 1 http://www.thestreet.com/_yahoo/story/10989791/1/biotech-calend
By Adam Feuerstein 01/31/11 - 09:10 AM EST
ALIM, AEN, EXEL, PLX, GENZ, IDIX, AVNR
BOSTON, Mass. (TheStreet) -- A calendar of important, potentially stock-
moving biotech events for February:
More from Adam Feuerstein
NPS Pharma: Gattex Bowel Study SucceedsArena Pharma: Weight-Loss Drug
WoesBiotech Stock Mailbag: Orexigen TherapeuticsMarket Activity
AVANIR Pharmaceuticals| AVNR DOWNAlimera Sciences Inc.| ALIM DOWNProtalix
BioTherapeutics Inc.| PLX UPFeb 1:
Discovery Labs(DSCO_): Surfaxin regulatory update conference call.
Earnings: Biogen Idec(BIIB_), Pfizer(PFE_).
Feb. 2
Earnings: Sangamo BioSciences(SGMO_), Viropharma(VPHM_).
Feb 3:
Alimera Sciences(ALIM_): 36-month results from phase III study of Iluvien in
diabetic macular edema.
Earnings: Alkermes(ALKS_), GlaxoSmithKline(GSK_), Avanir Pharmaceuticals(
AVNR_), Merck(MRK_), Vertex Pharmaceuticals(VRTX_),
Feb. 8:
Adeona Pharmaceuticals(AEN_) investor/analyst day.
Earnings: Seattle Genetics(SGEN_), Rigel Pharmaceuticals(RIGL_), Teva(TEVA_)
,
Feb. 9:
Earnings: Sanofi-Aventis(SNY_)
Feb. 10:
Earnings: Alexion Pharmaceuticals(ALXN_), Cephalon(CEPH_), Incyte
Pharmaceuticals(INCY_), MannKind(MNKD_), Momenta Pharmaceuticals(NNTA).
Feb 14-15:
BIO CEO & Investor Conference, New York City.
Feb 15:
Expiration of Sanofi-Aventis' $69-a-share tender offer for Genzyme(GENZ_).
Feb. 16:
Earnings: Genzyme
Feb. 17:
Exelixis(EXEL_): Presentation of updated cabozantinib (XL184) data in
prostate cancer at ASCO GU symposium
Earnings: Biomarin Pharmaceuticals(BMRN_), Acorda Therapeutics(ACOR_)
Feb. 22:
Earnings: Questcor Pharmaceuticals(QCOR_)
Feb 25:
Pfizer and Protalix Therapeutics(PLX_): FDA approval decision date for
Uplyso in Gaucher's disease.
Other potential February events
Idenix Pharmaceuticals(IDIX_): FDA decision on lifting clinical hold on
hepatitis C drugs IDX184 and IDX320.
Amylin Pharmaceuticals(AMLN_), Alkermes, Eli Lilly(LLY_): Start of a
Bydureon Qt study.
Source: Company reports, BioMedTracker.com | f**********g 发帖数: 2252 | 2 http://www.thestreet.com/_yahoo/story/10989791/1/biotech-calend
By Adam Feuerstein 01/31/11 - 09:10 AM EST
ALIM, AEN, EXEL, PLX, GENZ, IDIX, AVNR
BOSTON, Mass. (TheStreet) -- A calendar of important, potentially stock-
moving biotech events for February:
More from Adam Feuerstein
NPS Pharma: Gattex Bowel Study SucceedsArena Pharma: Weight-Loss Drug
WoesBiotech Stock Mailbag: Orexigen TherapeuticsMarket Activity
AVANIR Pharmaceuticals| AVNR DOWNAlimera Sciences Inc.| ALIM DOWNProtalix
BioTherapeutics Inc.| PLX UPFeb 1:
Discovery Labs(DSCO_): Surfaxin regulatory update conference call.
Earnings: Biogen Idec(BIIB_), Pfizer(PFE_).
Feb. 2
Earnings: Sangamo BioSciences(SGMO_), Viropharma(VPHM_).
Feb 3:
Alimera Sciences(ALIM_): 36-month results from phase III study of Iluvien in
diabetic macular edema.
Earnings: Alkermes(ALKS_), GlaxoSmithKline(GSK_), Avanir Pharmaceuticals(
AVNR_), Merck(MRK_), Vertex Pharmaceuticals(VRTX_),
Feb. 8:
Adeona Pharmaceuticals(AEN_) investor/analyst day.
Earnings: Seattle Genetics(SGEN_), Rigel Pharmaceuticals(RIGL_), Teva(TEVA_)
,
Feb. 9:
Earnings: Sanofi-Aventis(SNY_)
Feb. 10:
Earnings: Alexion Pharmaceuticals(ALXN_), Cephalon(CEPH_), Incyte
Pharmaceuticals(INCY_), MannKind(MNKD_), Momenta Pharmaceuticals(NNTA).
Feb 14-15:
BIO CEO & Investor Conference, New York City.
Feb 15:
Expiration of Sanofi-Aventis' $69-a-share tender offer for Genzyme(GENZ_).
Feb. 16:
Earnings: Genzyme
Feb. 17:
Exelixis(EXEL_): Presentation of updated cabozantinib (XL184) data in
prostate cancer at ASCO GU symposium
Earnings: Biomarin Pharmaceuticals(BMRN_), Acorda Therapeutics(ACOR_)
Feb. 22:
Earnings: Questcor Pharmaceuticals(QCOR_)
Feb 25:
Pfizer and Protalix Therapeutics(PLX_): FDA approval decision date for
Uplyso in Gaucher's disease.
Other potential February events
Idenix Pharmaceuticals(IDIX_): FDA decision on lifting clinical hold on
hepatitis C drugs IDX184 and IDX320.
Amylin Pharmaceuticals(AMLN_), Alkermes, Eli Lilly(LLY_): Start of a
Bydureon Qt study.
Source: Company reports, BioMedTracker.com
--Written by Adam Feuerstein in Boston.
>To contact the writer of this article, click here: Adam Feuerstein.
>To follow the writer on Twitter, go to http://twitter.com/adamfeuerstein.
>To submit a news tip, send an email to: t**[email protected]. |
|